Long Noncoding RNA Lnc-SNAPC5-3:4 Inhibits Malignancy by Directly Upregulating MiR-224-3p in Non-small Cell Lung Cancer

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Feb 5

PMID 38312596

Authors

Chenxi Hu

Shuo Wu

Wen Sun

Jiawen Li

Kaiyuan Hui

Xiaodong Jiang

Affiliations

Soon will be listed here.

Abstract

The mounting body of evidence demonstrates the growing importance of long noncoding RNAs in the advancement of tumors. This study aimed to investigate the molecular mechanism of lnc-SNAPC5-3:4 in non-small cell lung cancer (NSCLC). We investigated the expression of miR-224-3p and lnc-SNAPC5-3:4 in clinical NSCLC samples and NSCLC cell lines using reverse transcription polymerase chain reaction (RT-PCR). studies, A549 cell growth was estimated using Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EDU), and flow cytometry assays. studies, NSCLC tumorigenesis was determined using xenograft tumor mouse models, tumor growth was evaluated using antigen Kiel 67 (Ki67) staining, and tumor apoptosis was detected through terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The relationship between lnc-SNAPC5-3:4 and miR-224-3p was determined by luciferase reporter gene assay. Results indicated that the expression of lnc-SNAPC5-3:4 was observed to be downregulated in NSCLC tissues and cell lines. After overexpression of lnc-SNAPC5-3:4 in cultured A549 cells, proliferation decreased and apoptosis increased. Furthermore, the expression of miR-224-3p was targeted and negatively regulated by lnc-SNAPC5-3:4. The lnc-SNAPC5-3:4 upregulation inhibited cell proliferation and promoted apoptosis, which was partially blocked by miR-224-3p overexpression in A549 cells. In addition, we constructed a subcutaneous inoculation model using BALB/c nude mice, and the results indicated that lnc-SNAPC5-3:4 overexpression restrained the growth of subcutaneous tumors, decreased Ki67 expression levels, and increased apoptosis, as indicated by TUNEL staining in nude mice. However, miR-224-3p transfection resulted in the reversal of the inhibitory effect of lnc-SNAPC5-3:4 on tumor growth. In conclusion, our study revealed that lnc-SNAPC5-3:4 inhibits tumor progression in NSCLC by targeting miR-224-3p. This study provides a potential therapeutic target for inhibiting NSCLC progression.

References

Fang W, Shu S, Yongmei L, Endong Z, Lirong Y, Bei S . miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200. Sci Rep. 2016; 6:33229. PMC: 5018969. DOI: 10.1038/srep33229. View

Guo H, Chang Z, Wu J, Li W . Air pollution and lung cancer incidence in China: Who are faced with a greater effect?. Environ Int. 2019; 132:105077. DOI: 10.1016/j.envint.2019.105077. View

Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y . Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019; 11(18):7830-7846. PMC: 6781979. DOI: 10.18632/aging.102291. View

Wang G, Liu L, Zhang J, Huang C, Chen Y, Bai W . LncRNA HCG11 Suppresses Cell Proliferation and Promotes Apoptosis via Sponging miR-224-3p in Non-Small-Cell Lung Cancer Cells. Onco Targets Ther. 2020; 13:6553-6563. PMC: 7340369. DOI: 10.2147/OTT.S244181. View

Mao W, Guo Z, Dai Y, Nie J, Li B, Pei H . LNC CRYBG3 inhibits tumor growth by inducing M phase arrest. J Cancer. 2019; 10(12):2764-2770. PMC: 6584918. DOI: 10.7150/jca.31703. View

Zhao P, Zhao Q, Chen C, Lu S, Jin L . miR-4757-3p Inhibited the Migration and Invasion of Lung Cancer Cell via Targeting Wnt Signaling Pathway. J Oncol. 2023; 2023:6544042. PMC: 9940952. DOI: 10.1155/2023/6544042. View

Chao T, Kordass T, Osen W, Eichmuller S . SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines. Mol Cell Biochem. 2022; 478(2):305-315. PMC: 9886654. DOI: 10.1007/s11010-022-04507-z. View

Wang F, Gu T, Chen Y, Chen Y, Xiong D, Zhu Y . Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis. Bioengineered. 2021; 12(1):6724-6737. PMC: 8806559. DOI: 10.1080/21655979.2021.1955578. View

Wang G, Han J, Zhuang L, Li S, Gong Q, Chen Y . Serum starvation induces cell death in NSCLC via miR-224. Onco Targets Ther. 2019; 12:3953-3962. PMC: 6535431. DOI: 10.2147/OTT.S186613. View

10.

Han P, Zhao J, Gao L . Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer. J Clin Lab Anal. 2021; 35(11):e23979. PMC: 8605147. DOI: 10.1002/jcla.23979. View

11.

Xu R, Feng F, Yu X, Liu Z, Lao L . LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma. Cell Prolif. 2018; 51(6):e12515. PMC: 6528889. DOI: 10.1111/cpr.12515. View

12.

Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View

13.

Yan F, Zhao W, Xu X, Li C, Li X, Liu S . LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1. Front Cell Dev Biol. 2021; 8:585251. PMC: 7786137. DOI: 10.3389/fcell.2020.585251. View

14.

Yao X, Wang T, Sun M, Yuming Y, Guixin D, Liu J . Diagnostic value of lncRNA HOTAIR as a biomarker for detecting and staging of non-small cell lung cancer. Biomarkers. 2022; 27(6):526-533. DOI: 10.1080/1354750X.2022.2085799. View

15.

Hu Q, Ma H, Chen H, Zhang Z, Xue Q . LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside. Cell Death Discov. 2022; 8(1):359. PMC: 9376075. DOI: 10.1038/s41420-022-01157-4. View

16.

Jiao P, Tang P, Chu D, Li Y, Xu W, Ren G . Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth. Front Oncol. 2021; 11:756148. PMC: 8635526. DOI: 10.3389/fonc.2021.756148. View

17.

Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y . Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin. Mol Cancer. 2021; 20(1):162. PMC: 8662861. DOI: 10.1186/s12943-021-01455-y. View

18.

Liu C, Hu C, Chen T, Jiang Y, Zhang X, Liu H . The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer. J Cancer Res Clin Oncol. 2022; 148(10):2867-2879. DOI: 10.1007/s00432-022-04071-5. View

19.

Ghafouri-Fard S, Shoorei H, Branicki W, Taheri M . Non-coding RNA profile in lung cancer. Exp Mol Pathol. 2020; 114:104411. DOI: 10.1016/j.yexmp.2020.104411. View

20.

Ratti M, Lampis A, Ghidini M, Salati M, Mirchev M, Valeri N . MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol. 2020; 15(3):261-278. PMC: 7283209. DOI: 10.1007/s11523-020-00717-x. View